Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

NARecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2026

Conditions

Muscle-Invasive Bladder Carcinoma

Interventions

DEVICE

Varian Ethos Adaptive Radiation Therapy

Daily adaptive external beam radiation therapy delivered on Varian Ethos treatment system.

Trial Locations (1)

RECRUITING

Herlev and Gentofte Hospital, Herlev

All Listed Sponsors

collaborator

Herlev Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Varian, a Siemens Healthineers Company

INDUSTRY

NCT05295992 - Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach | Biotech Hunter | Biotech Hunter